Abstract
This bulletin outlines preliminary findings from the 308 cohort participants who completed both the Wave 1 and Wave 2 surveys, describing changes in drug use and behaviours, harm reduction behaviours, health ratings and drug/mental health treatment access and engagement pre- and post-COVID-19 restrictions (i.e., since March 2020).
Original language | English |
---|---|
Number of pages | 9 |
No. | 2 |
Specialist publication | Adapt Study |
Publisher | National Drug and Alcohol Research Centre, University of NSW |
Publication status | Published - Oct 2020 |
Keywords
- drug use
- COVID-19
- drug market
- drug policy